ARDELYX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.38 USD | -2.00% |
|
-4.92% | +2.90% |
| Apr. 17 | Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating | MT |
| Apr. 05 | Leerink Partners Initiates Coverage on Ardelyx With Outperform Rating, $14 Price Target | MT |
Chart calendar Ardelyx, Inc.
2c9c40b6d.aNA1i6XEPF9MH9TIXG9Nf1C3FAz8-6Wft4BKcEI4aPM.D-l55MqzUCl8VpaMNTx-Lz_1Q0CeifT17rMDKCgPJbspiXK4zodpFH1p4A~f80b2e12312c622a5d70b96fcd3b3fc9
Upcoming events on Ardelyx, Inc.
Past events on Ardelyx, Inc.
| 2024-03-05 10:30 am | TD Cowen Health Care Conference - Panel |
| 2024-02-22 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-22 04:01 pm | Q4 2023 Earnings Release |
| 2024-01-08 | Investor Meeting - Key Opinion Leader |
| 2023-11-29 02:30 pm | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-16 03:30 am | Jefferies London Healthcare Conference |
| 2023-11-03 10:00 am | American Society of Nephrology Kidney Conference - Poster Number: FR-PO318 |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster Number: TH-PO146 |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster Number: TH-PO147 |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster Number: TH-PO143 |
| 2023-10-31 08:00 am | Q3 2023 Earnings Call |
| 2023-10-31 07:00 am | Q3 2023 Earnings Release |
| 2023-10-18 08:00 am | XPHOZAH FDA Approval Call |
| 2023-09-11 12:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-06 | Gastroenterology & Hepatology Advanced Practice Providers Conference - A Subgroup Efficacy Analysis |
| 2023-09-06 | Gastroenterology & Hepatology Advanced Practice Providers Conference - Analysis of Patient-Reported |
| 2023-08-02 08:00 am | Q2 2023 Earnings Call |
| 2023-08-02 07:00 am | Q2 2023 Earnings Release |
| 2023-07-25 02:00 pm | H.C. Wainwright Kidney Conference |
| 2023-06-14 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,28 3,73 41.49% | 7,57 6,92 9.36% | 10,1 9,75 3.56% | 52,2 34,1 52.75% | 124 124 0.07% | 209 |
|
EBITDA Million USD | Released Forecast Spread | -88,8 -90,7 2.14% | -89,0 -84,9 -4.78% | -140 -154 9.19% | -51,9 -58,1 10.73% | -48,5 -46,7 -3.82% | -55,8 |
|
EBIT Million USD | Released Forecast Spread | -91,3 -94,5 3.39% | -90,8 -86,5 -4.94% | -154 -149 -3.86% | -63,8 -78,8 19.14% | -63,3 -56,0 -13.03% | -104 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,9 -96,9 2.06% | -94,3 -89,6 -5.32% | -158 -151 -4.95% | -67,2 -79,5 15.48% | -65,5 -59,3 -10.54% | -108 |
|
Net income Million USD | Released Forecast Spread | -94,9 -97,2 2.36% | -94,3 -89,6 -5.32% | -158 -151 -4.95% | -67,2 -78,5 14.4% | -66,1 -59,5 -11.07% | -107 |
|
EPS USD | Released Forecast Spread | -1,47 -1,53 3.8% | -1,05 -1,00 -4.82% | -1,52 -1,47 -3.68% | -0,42 -0,52 18.97% | -0,30 -0,27 -10.6% | -0,45 |
| Announcement Date | 06/03/20 | 08/03/21 | 28/02/22 | 02/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,03 0,88 17.53% | 0,47 0,88 -46.51% | 2,53 2,22 13.73% | 4,99 3,92 27.14% | 44,2 23,2 90.62% | 11,4 10,4 9.26% | 22,3 15,3 46.14% | 56,4 22,6 149.86% | 34,4 34,2 0.41% | 35,8 | 47,0 | 56,9 | 67,6 | 75,8 |
|
EBITDA Million USD | Released Forecast Spread | -31,4 | -23,7 -16,8 -40.64% | -22,7 -20,5 -11.05% | -19,6 -23,4 15.98% | 14,2 9,33 51.9% | -23,2 -17,1 -35.61% | -13,4 -18,8 28.73% | 11,2 -22,2 150.32% | -23,7 -16,6 -42.33% | -23,2 | -15,1 | -13,1 | -4,32 | 2,67 |
|
EBIT Million USD | Released Forecast Spread | -35,3 -28,0 -25.82% | -27,8 -25,6 -8.58% | -26,2 -25,0 -5.01% | -21,9 -24,5 10.52% | 12,1 -6,03 301.28% | -26,1 -19,3 -35.26% | -16,6 -23,3 28.75% | 7,40 -23,7 131.25% | -28,0 -20,7 -35.19% | -33,6 | -28,7 | -24,6 | -16,9 | -11,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,2 -28,8 -25.88% | -28,1 -26,3 -6.76% | -26,9 -25,5 -5.53% | -22,9 -25,2 9.07% | 10,7 -1,11 1065.25% | -26,8 -20,2 -32.18% | -17,1 -24,3 29.56% | 6,83 -24,8 127.58% | -28,5 -22,0 -29.13% | -34,5 | -29,8 | -25,7 | -18,0 | -12,3 |
|
Net income Million USD | Released Forecast Spread | -36,2 -28,8 -25.88% | -28,1 -26,3 -6.77% | -26,9 -25,5 -5.55% | -22,9 -25,2 9.07% | 10,7 -1,11 1065.25% | -26,8 -20,2 -32.25% | -17,1 -24,3 29.56% | 6,63 -24,8 126.77% | -28,8 -22,0 -30.64% | -34,3 | -29,6 | -25,1 | -17,8 | -12,6 |
|
EPS USD | Released Forecast Spread | -0,31 -0,26 -17.42% | -0,21 -0,22 2.33% | -0,19 -0,19 0% | -0,14 -0,17 16.83% | 0,06 -0,01 999.55% | -0,13 -0,10 -27.86% | -0,08 -0,12 30.43% | 0,03 -0,11 126.25% | -0,12 -0,10 -26.32% | -0,15 | -0,13 | -0,11 | -0,07 | -0,05 |
| Announcement Date | 28/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 03/05/23 | 02/08/23 | 31/10/23 | 22/02/24 | - | - | - | - | - |
More events
Past sector events for Ardelyx, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARDX Stock
- Calendar Ardelyx, Inc.
